I agree that the original intent of this board has been discontinued, but it is now a fact that Biocurex is juggling many potential revenue projects at one time. Dr Moro is trying to walk a fine line between delivering on what he has promised and not appearing to be overhyping. Why drop your pants if you don't have to. He was criticized for the comment "many irons in the fire" so he wants to divulge definitive news.

The rumor is that Inverness is working "with" Abbott on recaf. Inverness is not in the business of automated diagnostics (Abbott is) and corroborated the data at the ISOBM, in essence proving that they were willing to put their name with ours when presenting data about recaf. Inverness is into the rapid test (lateral flow) which is excluded in the Abbott license. In other words, recaf has a marlet specific to Abbott as well as one specific to Inverness. Dr Moro just a week ago said that Inverness is proceeding as anticipated. That was to clear the air on false rumors. He also said that in the real world things don't happen quite as fast as investors expect, but that does not mean that they are not still moving forward.

There is plenty to talk about, but it will be nice to get a brief message from Dr Moro every few weeks if it will reassure his loyal investors. It should be obvious that it is a symbiotic relationship where he needs us as much as we need him, so I agree it would be in his best interest to throw us a bone once in a while. Good luck to all.